1800PetMeds Revenue and Competitors
Estimated Revenue & Valuation
- 1800PetMeds's estimated annual revenue is currently $284.3M per year.
- 1800PetMeds's estimated revenue per employee is $1,106,109
- 1800PetMeds's current valuation is $502.4M. (January 2022)
Employee Data
- 1800PetMeds has 257 Employees.
- 1800PetMeds grew their employee count by 9% last year.
1800PetMeds's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and President | Reveal Email/Phone |
2 | Chief Marketing Officer | Reveal Email/Phone |
3 | Chief Technology and Information Officer | Reveal Email/Phone |
4 | VP People | Reveal Email/Phone |
5 | Head Site Optimization | Reveal Email/Phone |
6 | Director Information Technology | Reveal Email/Phone |
7 | Chief Marketing Officer | Reveal Email/Phone |
8 | Director Pharmacy Services | Reveal Email/Phone |
9 | Director FP&A | Reveal Email/Phone |
10 | Customer Care Director | Reveal Email/Phone |
1800PetMeds Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8550M | 14349 | 8% | $451M | $18.8B |
#2 | $35M | 103 | 5% | N/A | N/A |
What Is 1800PetMeds?
1-800-PetMeds is America’s largest pet pharmacy. We deliver prescription and non-prescription pet medications along with health and nutritional supplements for dogs and cats at substantial savings direct to the consumer. We service over one million customers nationwide from one location.
keywords:N/AN/A
Total Funding
257
Number of Employees
$284.3M
Revenue (est)
9%
Employee Growth %
$502.4M
Valuation
N/A
Accelerator
1800PetMeds News
2022-04-19 - Head-To-Head Analysis: PetMed Express (NASDAQ:PETS ...
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $80.2M | 270 | 9% | N/A |
#2 | $86.8M | 272 | 9% | N/A |
#3 | $87.1M | 276 | N/A | N/A |
#4 | $15M | 290 | 5% | N/A |
#5 | $15M | 296 | -10% | N/A |